03.01.12
Cardium Therapeutics, San Diego, CA, has entered a cross-strategic investment agreement with SourceOne Global Partners, Chicago, IL, that provides for the joint development and commercialization of customized nutritional supplements, as well as pharmaceuticals and medical foods. Products will be based on SourceOne’s branded ingredients, which include specialized formulations of EPA/DHA omega 3 oils, Citrus Polymethoxylated Flavonoids (PMFs, which have been used for promoting cholesterol balance and health), Ubiquinol-QH (a specialized CoQ10 formulation), TocoSource Palm Tocotrienols and VESIsorb (which is designed to enhance bioavailability of a variety of nutraceutical ingredients and dietary supplements).